Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.45 -0.04 (-7.29%)
As of: Oct 22, 2026 · 1:55 PM EDT

Pasithea Therapeutics (KTTA) Notes Payables (2023)

Updated

Pasithea Therapeutics (KTTA) recorded Notes Payables of $133,335 in Q2 2023, down 49.5% from the prior quarter.

Analysis

Pasithea Therapeutics (KTTA) Notes Payables (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,171.89 Bn 1,140.48 Bn 19.71 Bn
2 Johnson & Johnson 646.13 Bn 566.00 Bn 17.30 Bn
3 AbbVie 503.44 Bn 476.55 Bn 12.70 Bn
4 Merck 364.55 Bn 318.93 Bn 12.21 Bn
5 Novartis Ag 303.38 Bn 267.37 Bn 11.24 Bn
6 Astrazeneca 268.82 Bn 242.51 Bn 12.86 Bn
7 Amgen 242.30 Bn 197.70 Bn 7.24 Bn
8 Gilead Sciences 194.37 Bn 168.56 Bn 6.22 Bn
9 Pfizer 172.11 Bn 118.76 Bn 10.94 Bn
10 Pasithea Therapeutics 14.46 Mn -140.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 133,335.00
Mar 31, 2023 264,103.00
API Access

Pasithea Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=KTTA&period=max&api_key=YOUR_API_KEY